Intel Corporation (NASDAQ:INTC) Is Shipping A New Single-Board Computer- Biogen Inc. (BIIB)

Intel Corporation (NASDAQ:INTC) [Trend Analysis] retains strong position in active trade, as shares scoring -0.21% to $37.13 in a active trade session, while looking at the shares volume, around 2.15 Million shares have changed hands in this session. Intel (INTC) declared that it is shipping a new single-board computer, the Joule 550x, that will challenge the dominance of the Raspberry Pi. The board was reported in August but didn’t ship right away. The Joule 550x is a full-fledged computer on a small circuit board, and it packs more horsepower and graphics capabilities than the Raspberry Pi 3.

Intel’s recommended price for the Joule 550x is $149 to $159, and online retailer Mouser is selling it for $179, a sizable markup. At prices of up to $349, the Joule 550x development kit, with extra components, is more than double the price of Microsoft and Seeed Studio’s Raspberry Pi 3 starter kit called Seeed IoT Grove Kit for Windows, which sells for $149 and includes a 5-inch LCD screen. The kit is now accessible from online retailer Mouser and from Newegg for $291. The firm has institutional ownership of 66.60%, while insider ownership included 0.04%. INTC attains analyst recommendation of 2.20 with week’s performance of 1.11%. Investors looking further ahead will note that the Price to next year’s EPS is 5.36%.

Biogen Inc. (NASDAQ:BIIB) [Trend Analysis] knocking active thrust in leading trading session, shares a loss of -1.26% to 282.00 with around 422237 shares have changed hands in this session. Biogen (BIIB) declared that its BOD has appointed Michel Vounatsos as Chief Executive Officer and member of the Board of Directors, effective January 6, 2017.The company specified that Vounatsos will succeed George Scangos, who reported earlier this year his intention to step down after his replacement was found.

Vounatsos previously held the position of Executive Vice President and Chief Commercial Officer at Biogen, the company noted.Vounatsos joined Biogen in April 2016 after a 20 year career at Merck. While at Merck, he held leadership positions of increasing accountability in Europe, China, and the U.S., driving important and consistent growth across multiple geographies. The stock is going forward its fifty-two week low with 26.45% and lagging behind from its 52-week high price with -15.48%.

Similar, the positive performance for the quarter recorded as -8.46% and for the year was -4.02%, while the YTD performance remained at -6.78%. BIIB has Average True Range for 14 days of 8.67.

 

About Devon Leftovich

Leave a Reply

Your email address will not be published. Required fields are marked *